TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 81285200021

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81285200021 and manufactured by manufacturer not specified. The registration is held by FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMA with validity until Jan 27, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIO-RAD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81285200021
2 Related Devices
Registration Details
ANVISA Registration Number: 81285200021
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Teste Rápido Anti-HCV Bahiafarma (Ouro Coloidal)
Risk Class IV

Registration Details

81285200021

25351310889202467

13078518000190

Dates and Status

Jan 27, 2025

27/01/2035

09/18/2025 19:00:01

Teste Rápido Anti-HCV Bahiafarma (Ouro Coloidal)
Risk Class IV

Registration Details

81285200021

25351310889202467

13078518000190

Company Information

Dates and Status

Jan 27, 2025

27/01/2035

09/18/2025 19:00:01